Neurology® Podcast

In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about overcoming funding challenges, the importance of rigor and reputation, unmet needs in neurology, and leveraging AI in neurology research. Disclosures can be found at Neurology.org.

In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about recent advancements in neurology, emerging genomic therapies, the evolving understanding of long COVID, and current NINDS priorities. Disclosures can be found at Neurology.org.

In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about treatment options, real-world case studies, and future directions in myositis research. Disclosures can be found at Neurology.org.

In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about the different types of myositis, approaches to diagnosis, available diagnostic tools, and the evolving roles of MRI and biopsy in clinical practice. Disclosures can be found at Neurology.org.

The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients’ perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. The replay concludes with Dr. Katie Krulisky’s conversation with Dr. Leah Blank on how outpatient follow-up impacts readmission rates in older adults with epilepsy or seizures Podcast links: The Effect of Epilepsy Surgery on Tonic–Clonic Seizures Patient Perspectives on Antiseizure Medication Discontinuation Understanding Acute Symptomatic Seizures Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge Article links: The Effect of Epilepsy Surgery on Tonic–Clonic Seizures Patient Perspectives on Antiseizure Medication Discontinuation Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older Disclosures can be found at Neurology.org.

Dr. Alex Menze talks with Dr. Christopher J. Klein about the clinical presentation, diagnosis, and management of diabetic lumbosacral radiculoplexus neuropathy and common fibular neuropathy in the context of GLP-1RA. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Valtteri Kaasinen about the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Trey Bateman talks with Dr. David T. Jones about how the StateViewer system leverages FDG-PET imaging and machine learning to improve diagnostic accuracy and clinical decision-making for Alzheimer disease and related disorders. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation. Read the related article in The Lancet. Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Drs. Michael A. Van Es and Eva de Boer about the current diagnostic criteria for PLS, the role of genetic testing, and the clinical implications for patient management. Read the related article in Neurology. Read the additional related article mentioned in this episode. Disclosures can be found at Neurology.org.

Dr. BJ Hicks talks with Drs. Birgitte Hede Ebbesen and Boris Modrau about the study's methodology, findings, and implications for clinical practice, emphasizing the need for better awareness and support for TIA patients. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Casey R. Vanderlip about whether the accelerated decline in episodic memory among APOE4 carriers is due to increased Aβ deposition or heightened susceptibility to Aβ-related effects. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Halley Alexander talks with Dr. Juan Luis Alcala-Zermeno about the outcomes of epilepsy surgery, specifically for patients with tonic-clonic seizures. Read the related article in Epilepsia. Read the additional related article in Epilepsia. Listen to the previous podcast episode mentioned in this episode. Disclosures can be found at Neurology.org.

The August 2025 recall spotlights four previously released episodes on topics related to dementia diagnosis. The episode begins with Dr. Amy Brodtmann discussing the complexities of diagnosing frontotemporal dementia in clinical practice. Next, Dr. Joseph Therriault delves into the use of plasma biomarkers in diagnosing Alzheimer disease. In the third episode, Dr. Trey Bateman discusses the growing significance of blood-based biomarkers in Alzheimer disease. The episode concludes with Dr. Gregg Day discussing the clinical implications of using plasma biomarkers in real-world patient care. Podcast links: Frontotemporal Dementia Differential Diagnosis in Clinical Practice Diagnosis of Alzheimer Disease Using Plasma Biomarkers Understanding Blood-Based Biomarkers in Alzheimer Disease Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic Article links: Frontotemporal Dementia Differential Diagnosis in Clinical Practice Diagnosis of Alzheimer’s Disease Using Plasma Biomarkers Adjusted to Clinical Probability Diagnostic Performance of Plasma p-tau217 and Aβ42/40 Biomarkers in the Outpatient Memory Clinic Disclosures can be found at Neurology.org.

Dr. Kathryn Krulisky talks with Dr. Jordan Garris about educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. Read the related article in Neurology Education. Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadasatinib as a treatment option for giant-cell arteritis. Read the related article in The New England Journal of Medicine. Disclosures can be found at Neurology.org.

Dr. Jason Crowell talks with Dr. Daniel Weintraub about clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease. Read the related article in Neurology. Listen to the related podcast episode with Dr. Jeff Ratliff. Disclosures can be found at Neurology.org.

Dr. Dan Ackerman talks with Dr. James Ernest Siegler about the complexities of treating ESUS and emphasizes the importance of personalized treatment approaches based on individual patient factors. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Trey Bateman talks with Dr. Gregg Day about the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care. Read the related article in Alzheimer's & Dementia. Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Eric L. Voorn about the efficacy of combined personalized home-based aerobic exercise and coaching on physical fitness in people with neuromuscular diseases, compared with usual care. Read the related article in Neurology. Read the additional article that was referenced. Disclosures can be found at Neurology.org.